FDA Panel Endorses Gene Therapy For A Form Of Childhood Blindness

FDA Panel Endorses Gene Therapy For A Form Of Childhood Blindness
A panel of experts has recommended that the Food and Drug Administration approve a treatment developed by Spark Therapeutics for a rare form of blindness.

After many setbacks for genetic therapies, advisers to the Food and Drug Administration recommended approval of the first gene treatment for an inherited form of blindness.

(Image credit: Spark Therapeutics)